Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	1655.61	11.46	0.65
Graham Fair Price	9640.39	29.39	0.30
PEG	-73.92	< 0.005	0.03
Price/Book	-99.98	0.03	182.47
Price/Cash Flow	-89.35	0.77	7.26
Prices/Earnings	-22.07	0.31	0.40
Price/Sales	11.87	0.20	0.18
Price/FCF	-89.35	0.77	7.26
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	0.23	0.66	0.66
Operating Margin	-0.46	0.19	0.19
ROA	-99.97	0.01	42.94
ROE	114.25	0.03	-99.98
ROIC	128.15	0.02	-99.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	67875.01	-0.04	189315880.35
Dividends QOQ	< 0.005	< 0.005	-98.85
EBIT QOQ	0.08	< 0.005	-89.54
EPS QOQ	0.15	0.46	198.86
FCF QOQ	-0.62	9.64	1464.62
Revenue QOQ	0.04	0.01	-64.08
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	186.04	567638844665.34
Days Sales Outstanding (DSO)	0.05	66.40	126333.39
Inventory Turnover	2746000000.00	0.48	-100.00
Debt/Capitalization	0.04	0.33	634.28
Quick Ratio	1.21	1.46	20.21
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	< 0.005	38.79	651568.33
Cash	< 0.005	6.23	84073.34
Capex	-0.34	-0.26	24.87
Free Cash Flow	0.15	1.59	965.12
Revenue	5.97	6.06	1.42
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.21	2.30	89.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	< 0.005	10.71	248362.85
Naive Interpretation	Member

06 - Financial Health · Bad

Rating